Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

被引:1
作者
Ye, Shuai [1 ]
Han, Yu [2 ]
Pan, Ximin [1 ]
Niu, Kexin [1 ]
Liao, Yuting [3 ]
Meng, Xiaochun [1 ]
机构
[1] Sun Yat sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[2] Sun Yat sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China
[3] GE Healthcare Pharmaceut Diagnost, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
radiomics; computed tomography; progression-free survival; colorectal liver metastases; chemotherapy;
D O I
10.3389/fonc.2023.1283480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer
    Fan, Shuxuan
    Cui, Xiaonan
    Liu, Chunli
    Li, Xubin
    Zheng, Lei
    Song, Qian
    Qi, Jin
    Ma, Wenjuan
    Ye, Zhaoxiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival
    Okuno, Masayuki
    Hatano, Etsuro
    Seo, Satoru
    Taura, Kojiro
    Yasuchika, Kentaro
    Nakajima, Akio
    Yazawa, Takefumi
    Furuyama, Hiroaki
    Kawamoto, Hiroshi
    Yagi, Shintaro
    Nishitai, Ryuta
    Fujikawa, Takahisa
    Arimoto, Akira
    Zaima, Masazumi
    Yoshimura, Tsunehiro
    Terajima, Hiroaki
    Kaihara, Satoshi
    Manaka, Dai
    Tanaka, Akira
    Uemoto, Shinji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2014, 21 (12) : 881 - 888
  • [43] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [44] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [45] CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
    Zeng, Fanyuan
    Ye, Zhuomiao
    Zhou, Qin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (02)
  • [46] CT-based peritumoral radiomics nomogram on prediction of response and survival to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
    Fanyuan Zeng
    Zhuomiao Ye
    Qin Zhou
    Journal of Cancer Research and Clinical Oncology, 150
  • [47] Radiomics of dual-energy computed tomography for predicting progression-free survival in patients with early glottic cancer
    Li, Wenfei
    Zhang, Huanlei
    Ren, Lei
    Zou, Ying
    Tian, Fengyue
    Ji, Xiaodong
    Li, Qing
    Wang, Wei
    Ma, Guolin
    Xia, Shuang
    FUTURE ONCOLOGY, 2022, 18 (15) : 1873 - 1884
  • [48] Preoperative CT-based morphological heterogeneity for predicting survival in patients with colorectal cancer liver metastases after surgical resection: a retrospective study
    Xing, Qian
    Cui, Yong
    Liu, Ming
    Gu, Xiao-Lei
    Li, Xiao-Ting
    Xing, Bao-Cai
    Sun, Ying-Shi
    BMC MEDICAL IMAGING, 2024, 24 (01):
  • [49] Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases
    Florian E. Buisman
    Eric P. van der Stok
    Boris Galjart
    Peter B. Vermeulen
    Vinod P. Balachandran
    Robert R. J. Coebergh van den Braak
    John M. Creasy
    Diederik J. Höppener
    William R. Jarnagin
    T. Peter Kingham
    Pieter M. H. Nierop
    Eran Sadot
    Jinru Shia
    Bas Groot Koerkamp
    Dirk J. Grünhagen
    Michael D’Angelica
    Cornelis Verhoef
    Clinical & Experimental Metastasis, 2020, 37 : 593 - 605
  • [50] Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases
    van Kessel, C. S.
    Samim, M.
    Koopman, M.
    van den Bosch, A. A. J.
    Rinkes, I. H. M. Borel
    Punt, C. J. A.
    van Hillegersberg, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (11) : 2486 - 2493